On April 25, during the 8th Qihuang Forum, the Chinese Medicine Society announced the 2025 Science and Technology Awards results. Beijing University of Chinese Medicine (BUCM) emerged prominently, obtaining 11 awards as the primary institution. The accolades include two first prizes, two second prizes, and two third prizes in the Science and Technology category, alongside two Li Shizhen Pharmaceutical Innovation Awards and three Young Scientist Innovation Awards. This achievement underscores BUCM's robust research capabilities and innovative vigor.

The university prioritized the award application process, executing a detailed strategy involving policy briefings, precise application coordination, rigorous reviews, expert evaluations, and transparent recommendations. This comprehensive effort, supported by the commitment of BUCM's researchers and the effective collaboration of its research management teams, culminated in this remarkable success.

These awards affirm BUCM's prowess in research innovation, academic development, and talent cultivation. They reflect the university's enduring dedication to the tradition and innovation of Chinese medicine and its focused research endeavors. Furthermore, these accomplishments bolster BUCM's leading status in the national Chinese medicine research arena, injecting significant momentum into the modernization and industrialization of Chinese medicine. The recognition also motivates BUCM's researchers to delve deeper into core areas of traditional Chinese medicine, contributing their expertise and energy to the field's high-quality development.